PINK1 and asthma: Asthma: Preclinical study showed suppression of neutrophilic airway inflammation (59)Neutrophilic asthma: Preclinical study demonstrated reduction of airway inflammation and AHR (142)Allergic rhinitis: Preclinical study demonstrated enhanced PINK1/Parkin-mediated mitophagy, reduced inflammation, oxidative stress, and apoptosis (143)